Axios Re:Cap

The vaccine race hits a speed bump

Yesterday news broke that AstraZeneca is pausing its clinical trials on a COVID-19 vaccine after a patient appeared to develop a serious neurological condition. It raised an unsettling question: What if a vaccine is further away than most of us have hoped? Dan unpacks the latest reporting and what it means with STAT News reporter Adam Feuerstein, who helped break the AstraZeneca news.
Learn more about your ad choices. Visit megaphone.fm/adchoices

Each weekday afternoon, Axios unpacks the biggest story of the day and why it matters. We'll take you inside the accelerating forces, technologies and trends that are remaking your world and work. About Axios: Axios is a digital media company launched in 2017. Axios - which means “worthy” in Greek - helps you become smarter, faster with news and information across politics, tech, business, media, science and the world. Subscribe to our newsletters at axios.com/newsletters and download our mobile app at axios.com/app. 

Axios Re:Cap is on hiatus until October 2021.